Editorial Archive Archives - Page 20 of 39 - Journal for Clinical Studies

Current Edition

Editorial Archive

Advancing Age and the Impact on the Central Haemodynamics

As a result of the aging process, significant changes occur in the arterial system. Increases in the brachial systolic and pulse blood pressures and the initial inc...

20 August 2015 Editorial Archive | Volume 7 Issue 4 | Watch Pages V7 I4

Continue Reading →

Editorial Archive

Clinical Trial Retention Meta-Analysis – How Patient Recruitment Methods Directly Rate to the Retention of Subjects.

Patient recruitment methods can have a significant effect on the retention of subjects in clinical trials; these effects can result in considerable cost implications....

15 June 2015 Editorial Archive | IT & Logistics V7 I3 | Volume 7 issue 3

Continue Reading →

Editorial Archive

Unlocking the Potential of Social Media in Drug Safety

Drug safety and Pharmacovigilance (PV) have evolved and grown significantly more complex over the past decade due to higher data volumes, evolving regulations, increa...

15 June 2015 Editorial Archive | IT & Logistics V7 I3 | Volume 7 issue 3

Continue Reading →

Editorial Archive

Methodological Issues in the Design and Conduct of Opioid Use Disorders Clinical Trials

Opioid use disorders have significantly increased over the past two decades, affecting between 26 and 36 million people worldwide. There are several unique methodolog...

15 June 2015 Editorial Archive | Therapeutics V7 I3 | Volume 7 issue 3

Continue Reading →

Editorial Archive

Parkinson’s Disease – Functional Imaging of the Dopamine Pathway

The diagnosis of movement disorders and neurodegenerative diseases can be problematic for clinicians and radiologists alike. There is considerable overlap in the earl...

15 June 2015 Editorial Archive | Therapeutics V7 I3 | Volume 7 issue 3

Continue Reading →

Editorial Archive

Raising Clinical Trial Standards through Competency-Based Training

The Clinical Trial Directive – 2001/20/EC – has been in place for about a decade. In that time the number of drug trials conducted in the EU has fallen by about 25%.(...

15 June 2015 Editorial Archive | Market Report V7 I3 | Volume 7 issue 3

Continue Reading →

Editorial Archive

From Clinical Trial to Real World Outcomes

The need for costly clinical trials in order to bring a drug successfully to market is undoubtable. However, outside of this carefully controlled, highly supportive e...

15 June 2015 Editorial Archive | Market Report V7 I3 | Volume 7 issue 3

Continue Reading →

Editorial Archive

Orphan Drug Designations – Are the EMA and FDA looking for the same Information?

Whilst working on a recent European application for an Orphan Drug Designation (ODD) for a rare neurological condition that was being made to the EMA, I noticed that ...

15 June 2015 Editorial Archive | Regulatory V7 I3

Continue Reading →

Editorial Archive

Common Pitfalls of RECIST 1.1 Application in Clinical Trials

Revised Response Evaluation Criteria in Solid Tumours (RECIST 1.1) came into effect in 2009 in order to address the issues and limitations of RECIST 1.0. While RECIST...

15 June 2015 Editorial Archive | Regulatory V7 I3

Continue Reading →

Editorial Archive

Supplier Qualification: A Review

It is a GMP requirement to certify the vendor to deliver high quality and safe medicines, and to prevent recalls, deaths, adverse events, and serious illness due to s...

15 June 2015 Editorial Archive | Regulatory V7 I3

Continue Reading →